Literature DB >> 32435339

Prevalence and Factors Associated with Atrial Fibrillation Among Patients with Rheumatic Heart Disease.

Sahadeb Prasad Dhungana1, Rajesh Nepal1, Rinku Ghimire2.   

Abstract

INTRODUCTION: Rheumatic heart disease (RHD) is one of the common causes of atrial fibrillation (AF) is associated with significant morbidity and mortality. There is a lack of data on the prevalence of AF and factors associated with increased risk of AF in patients with RHD from Nepal.
METHODS: A total of 120 patients who received care at Nobel Medical College Teaching Hospital from January 2018 to February 2019 with a diagnosis of RHD with AF were enrolled. Demographic information, relevant clinical and laboratory parameters and predisposing conditions for AF were obtained from a structured questionnaire designed.
RESULTS: The prevalence of AF was 120 (36.3%) out of 330 cases of RHD screened. The male to female ratio was 32:88. The mean age was 50.2 (range 22-80) years. Prevalence was slightly more in females (36.9%) as compared to males (34.7 %). The prevalence of AF in patients with predominant mitral stenosis (MS) was 66.6% and less in patients with predominant mitral regurgitation (MR) (16.6%). The prevalence of AF in cases of MS with mitral valve area (MVA) < 1.5 cm2 was 76.2% as compared to 23.7% in cases with MVA > 1.5 cm2. Mitral valve (MV) was the most commonly affected valve (83.3%) followed by the aortic valve (10%). Both mitral and aortic valves were involved in 6.6% of patients. Majority of patients (97.5%) had enlarged left atrium (>40mm), reduced estimated glomerular filtration rate (eGFR) of <90 ml/min (85.8%). Patients of RHD with AF were complicated with decreased left ventricular (LV) systolic function (67.5%), pulmonary artery hypertension (52.5%), left atrial clot (9.1%), stroke (8.3%), and peripheral embolism (2.5%).
CONCLUSIONS: AF is a common rhythm disorder in patients with RHD. Prevalence of AF is common in females, increases with age, increasing LA size, increased severity of MS and decreased level of eGFR.

Entities:  

Keywords:  Atrial fibrillation; Prevalence; Rheumatic heart disease; Risk factors

Year:  2019        PMID: 32435339      PMCID: PMC7237075          DOI: 10.4022/jafib.2143

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  17 in total

Review 1.  Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients With Heart Failure: A Meta-Analysis of Randomised Controlled Trials.

Authors:  Sohaib A Virk; Richard G Bennett; Clara Chow; Prashanthan Sanders; Jonathan M Kalman; Stuart Thomas; Saurabh Kumar
Journal:  Heart Lung Circ       Date:  2018-11-17       Impact factor: 2.975

Review 2.  Systematic review and meta-analysis on management of acute urinary retention.

Authors:  P D Yoon; V Chalasani; H H Woo
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

4.  Standardisation of perioperative urinary catheter use to reduce postsurgical urinary tract infection: an interrupted time series study.

Authors:  Mahsa Sadeghi; Jerome A Leis; Claude Laflamme; Darrel Sparkes; Wendy Ditrani; Aaron Watamaniuk; Ru Taggar; Fatema Jinnah; Melisa Avaness; Mary Vearncombe; Avery B Nathens
Journal:  BMJ Qual Saf       Date:  2018-05-29       Impact factor: 7.035

5.  Early Urinary Catheter Removal Following Pelvic Colorectal Surgery: A Prospective, Randomized, Noninferiority Trial.

Authors:  Devin N Patel; Seth I Felder; Michael Luu; Timothy J Daskivich; Karen N Zaghiyan; Phillip Fleshner
Journal:  Dis Colon Rectum       Date:  2018-10       Impact factor: 4.585

6.  Omitting perioperative urinary catheterization in laparoscopic cholecystectomy: a single-institution experience.

Authors:  Tsuyoshi Hata; Takehiro Noda; Junzo Shimizu; Hisanori Hatano; Keizo Dono
Journal:  Surg Today       Date:  2016-12-09       Impact factor: 2.549

7.  Interventions to prevent urinary catheter-associated infections in children and neonates: a systematic review.

Authors:  A R Araujo da Silva; A F Marques; C Biscaia di Biase; W Zingg; A Dramowski; M Sharland
Journal:  J Pediatr Urol       Date:  2018-07-21       Impact factor: 1.830

Review 8.  Post-operative urinary retention.

Authors:  Martin Steggall; Colm Treacy; Mark Jones
Journal:  Nurs Stand       Date:  2013 Oct 2-8

9.  Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation.

Authors:  Takanori Yamaguchi; Yusuke Shimakawa; Shinji Mitsumizo; Akira Fukui; Yuki Kawano; Toyokazu Otsubo; Yuya Takahashi; Kei Hirota; Takeshi Tsuchiya; Kenichi Eshima
Journal:  J Cardiol       Date:  2018-01-17       Impact factor: 3.159

Review 10.  Urinary catheters: history, current status, adverse events and research agenda.

Authors:  Roger C L Feneley; Ian B Hopley; Peter N T Wells
Journal:  J Med Eng Technol       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.